17-7191360-T-C
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The ENST00000489885.1(DLG4):n.876A>G variant causes a non coding transcript exon change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
ENST00000489885.1 non_coding_transcript_exon
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- intellectual developmental disorder 62Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DLG4 | ENST00000399506.9 | c.1977-2A>G | splice_acceptor_variant, intron_variant | Intron 18 of 19 | 2 | NM_001321075.3 | ENSP00000382425.2 | |||
DLG4 | ENST00000648172.9 | c.2106-2A>G | splice_acceptor_variant, intron_variant | Intron 20 of 21 | ENSP00000497806.3 | |||||
DLG4 | ENST00000648896.1 | c.2076-2A>G | splice_acceptor_variant, intron_variant | Intron 18 of 19 | ENSP00000497546.1 | |||||
DLG4 | ENST00000649520.1 | c.1797-2A>G | splice_acceptor_variant, intron_variant | Intron 17 of 18 | ENSP00000497647.1 | |||||
DLG4 | ENST00000491753.2 | n.1996-2A>G | splice_acceptor_variant, intron_variant | Intron 19 of 20 | 2 | ENSP00000467897.2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Pathogenic:1
This variant has been observed in individual(s) with clinical features of DLG4-related conditions (Invitae). In at least one individual the variant was observed to be de novo. For these reasons, this variant has been classified as Pathogenic. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in DLG4 are known to be pathogenic (PMID: 27479843, 29460436). Experimental studies and prediction algorithms are not available or were not evaluated, and the effect of this variant on mRNA splicing is currently unknown. This variant is not present in population databases (ExAC no frequency). This sequence change affects an acceptor splice site in intron 20 of the DLG4 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at